T0	Outcomes 305 324	efficacy and safety
T1	Outcomes 757 901	(anorexia, nausea, vomiting, upper abdominal pain, postprandial bloating, abdominal fullness, early satiety, belching, heartburn, regurgitation)
T2	Outcomes 1163 1171	efficacy
T3	Outcomes 1495 1546	(postprandial bloating, epigastric pain, heartburn)
T4	Outcomes 1659 1714	galactorrhoea, breast tenderness and menstrual changes.